A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: A promising path for progress emerges

被引：20
|
作者：
Sausville, EA [1 ]
机构：
[1] NCI, Dev Therapeut Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 02期
关键词：
D O I：
10.1093/jnci/91.2.102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [1] BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia
    Schiffer, Charles A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 258 - 265
  • [2] Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia
    O'Dwyer, ME
    Druker, BJ
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (06) : 594 - 597
  • [3] Chronic Myelogenous Leukemia, BCR-ABL1+
    Vardiman, James W.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 250 - 260
  • [4] THE BCR-ABL GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    SAWYERS, CL
    CANCER SURVEYS, 1992, 15 : 37 - 51
  • [5] BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemia
    Gruenebach, Frank
    Mirakaj, Valbona
    Mirakaj, Valdete
    Mueller, Martin R.
    Bruemmendorf, Tim
    Brossart, Peter
    CANCER RESEARCH, 2006, 66 (11) : 5892 - 5900
  • [6] FUSED TRANSCRIPT OF ABL AND BCR GENES IN CHRONIC MYELOGENOUS LEUKEMIA
    SHTIVELMAN, E
    LIFSHITZ, B
    GALE, RP
    CANAANI, E
    NATURE, 1985, 315 (6020) : 550 - 554
  • [7] CHRONIC MYELOGENOUS LEUKEMIA BCR/ABL POSITIVE COMPLICATING A PREGNANCY
    Tello, E. Juarez Ramirez
    Sultan, A.
    Khan, S.
    Tijani, L.
    Nugent, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 475 - 475
  • [8] BCR-ABL RNA IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    SHTIVELMAN, E
    GALE, RP
    DREAZEN, O
    BERREBI, A
    ZAIZOV, R
    KUBONISHI, I
    MIYOSHI, I
    CANAANI, E
    BLOOD, 1987, 69 (03) : 971 - 973
  • [9] BCR ABL GENE REARRANGEMENT IN CHRONIC MYELOGENOUS LEUKEMIA AND ACUTE LEUKEMIAS
    CRISAN, D
    CARR, ER
    LABORATORY MEDICINE, 1992, 23 (11) : 730 - 736
  • [10] The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia
    Jessica Fredericks
    Ruibao Ren
    Frontiers of Medicine, 2013, 7 : 452 - 461
12345